Virax Biolabs Reports 92% Accuracy for Long COVID Diagnostic Test
Virax Biolabs reports 92% accuracy for Long COVID diagnostic test ViraxImmune™ in pilot study, planning larger validation trial with Q1 2027 results.
VRAXbiomarkersclinical validation